Breast Cancer FemaleVMSNCT06277141
The Vitality Mammography Messaging Study
A study testing Standard message, Radiology booking site link. and Radiology practice telephone numbers in people with Breast Cancer Female, run by Wits Health Consortium (Pty) Ltd at 1 site in South Africa.
Trial summary
The investigators will be conducting a randomized controlled trial amongst members of a Wellness Program to test receipt of mammogram using the Whatsapp social media platform and testing various messages. Read more about this study
- Who is it for?
- Ages 50 to 75 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Breast Cancer Female
- What is being tested?
- Standard message, Radiology booking site link. and Radiology practice telephone numbers
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 7,655 participants
- Where
- 1 siteSouth Africa
- Study dates
- 27 Sep 2023to 31 Mar 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 75 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Females aged 50 to 75 years, who are members of the Discovery Health Medical Plan and who are also members of Vitality and who have not had a screening mammogram in the preceding three years and who have not previously been diagnosed with breast cancer.
Who cannot join
- CPA Blocks
- If member's address location, based on their Discovery profile, was further than 5km radius to the Radiologist practice
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Vitality Mammography Study - Testing the Effectiveness of a Booking Platform on Receipt of Screening Mammography - a Randomized Controlled Trial.
The investigators will be conducting a randomized controlled trial amongst members of a Wellness Program to test receipt of mammogram using the Whatsapp social media platform and testing various messages.
Read the detailed description
The investigators will be conducting a randomised control trial to test the efficacy of WhatsApp messages to increase receipt of mammography amongst eligible women who are members of the Vitality health promotion programme and are also on the Discovery Health Medical Scheme. The study will test a message that 1) has a link to a platform created by the Radiology Society of South Africa which allow members to select a range of practices to book a mammogram, against 2) a message that gives names and telephone numbers of Radiology practices in a 5 km radius of the members home address, against 3) a group with a link to an online platform as well as telephone numbers of radiology practices, against 4) a group where a standard message reminding to go for mammogram will be sent, but without names and telephone numbers of the radiology practices, against 5) a control group where no messages relating to mammography will be sent.
- Conditions
- Breast Cancer Female
- Being tested
- Standard message, Radiology booking site link., Radiology practice telephone numbers, Radiology site link and telephone numbers
- Keywords
- Mammography, Screening, Social Media
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard messageBehavioural
Participants will receive standard messaging based on the Cancer Association of South Africa (CANSA) recommendation on breast cancer screening and a reminder to screen for breast cancer.
Radiology booking site link.Behavioural
Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site.
Radiology practice telephone numbersBehavioural
Participants will receive a reminder to screen for breast cancer together with a list and telephone numbers of radiology practices
Radiology site link and telephone numbersBehavioural
Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site and a list and telephone numbers of radiology practices
| Study group | Role | What they receive |
|---|---|---|
| Standard message | Experimental | standard message reminder to screen for breast cancer. Receives: Behavioral: Standard message |
| Radiology Booking Site Link | Experimental | Message with an online link to a radiology practice booking site. Receives: Behavioral: Radiology booking site link. |
| Radiology practice telephone numbers | Experimental | Message with a list and telephone numbers of radiology practices. Receives: Behavioral: Radiology practice telephone numbers |
| Control - no message | No intervention | Participants will not receive any messaging regarding mammography. |
| Radiology booking site link and telephone numbers. | Experimental | Message with a direct online link to a radiology practice booking site and telephone numbers of radiology practices. Receives: Behavioral: Radiology site link and telephone numbers |
What is being measured
The primary outcome is the main question the study is designed to answer.
Comparison of mammography screening rates using WhatsApp
Comparison of mammography screening rates using an online radiology booking platform, a message with a radiology practice number, to a standard message, all delivered by WhatsApp.
Measured: Five months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Feb 2024
- Study start27 Sep 2023
- Primary completion29 Feb 2024
- Study completion31 Mar 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast Cancer FemaleStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized controlled trial
- Masking
- None (open label)
- Enrolment
- 7,655 participants (actual)
Sponsor and investigators
- Lead sponsor
- Wits Health Consortium (Pty) Ltd
- Sponsor type
- University, hospital or other
- Collaborators
- Discovery Vitality
- Responsible party
- Sponsor
- Investigators
- Adele Walker, Principal investigator, Discovery
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06277141
- Sponsor's protocol ID
- M230742
- Acronym
- VMS
- Status last verified
- Feb 2025
- First submitted
- 27 Oct 2023
- Last updated
- 10 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Anonymized data will be shared with Wits collaborators
Study at a glance
From the registry record, last updated by the sponsor on 10 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Vitality Mammography Study - Testing the Effectiveness of a Booking Platform on Receipt of Screening Mammography - a Randomized Controlled Trial.
- ClinicalTrials.gov ID
- NCT06277141
- Acronym / sponsor ID
- VMS / M230742
- Conditions
- Breast Cancer Female
- Keywords
- Mammography, Screening, Social Media
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 7,655 participants (actual)
- Lead sponsor
- Wits Health Consortium (Pty) LtdUniversity, hospital or other
- Collaborators
- Discovery Vitality
- Study start
- 27 Sep 2023 (actual)
- Primary completion
- 29 Feb 2024 (actual)
- Study completion
- 31 Mar 2024 (actual)
- First posted
- 26 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators will be conducting a randomized controlled trial amongst members of a Wellness Program to test receipt of mammogram using the Whatsapp social media platform and testing various messages.
Detailed description
The investigators will be conducting a randomised control trial to test the efficacy of WhatsApp messages to increase receipt of mammography amongst eligible women who are members of the Vitality health promotion programme and are also on the Discovery Health Medical Scheme. The study will test a message that 1) has a link to a platform created by the Radiology Society of South Africa which allow members to select a range of practices to book a mammogram, against 2) a message that gives names and telephone numbers of Radiology practices in a 5 km radius of the members home address, against 3) a group with a link to an online platform as well as telephone numbers of radiology practices, against 4) a group where a standard message reminding to go for mammogram will be sent, but without names and telephone numbers of the radiology practices, against 5) a control group where no messages relating to mammography will be sent.
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 5
- Model description
- Randomized controlled trial
| Arm | Type | Receives |
|---|---|---|
| Standard message | Experimental | Behavioral: Standard messagestandard message reminder to screen for breast cancer. |
| Radiology Booking Site Link | Experimental | Behavioral: Radiology booking site link.Message with an online link to a radiology practice booking site. |
| Radiology practice telephone numbers | Experimental | Behavioral: Radiology practice telephone numbersMessage with a list and telephone numbers of radiology practices. |
| Control - no message | No intervention | –Participants will not receive any messaging regarding mammography. |
| Radiology booking site link and telephone numbers. | Experimental | Behavioral: Radiology site link and telephone numbersMessage with a direct online link to a radiology practice booking site and telephone numbers of radiology practices. |
Who may qualify
- Ages
- 50 to 75 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Females aged 50 to 75 years, who are members of the Discovery Health Medical Plan and who are also members of Vitality and who have not had a screening mammogram in the preceding three years and who have not previously been diagnosed with breast cancer.
Key exclusion criteria (2 listed)
- CPA Blocks
- If member's address location, based on their Discovery profile, was further than 5km radius to the Radiologist practice
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Standard messageParticipants will receive standard messaging based on the Cancer Association of South Africa (CANSA) recommendation on breast cancer screening and a reminder to screen for breast cancer. | Behavioural | Standard message |
| Radiology booking site link.Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site. | Behavioural | Radiology Booking Site Link |
| Radiology practice telephone numbersParticipants will receive a reminder to screen for breast cancer together with a list and telephone numbers of radiology practices | Behavioural | Radiology practice telephone numbers |
| Radiology site link and telephone numbersParticipants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site and a list and telephone numbers of radiology practices | Behavioural | Radiology booking site link and telephone numbers. |
Primary outcome
Comparison of mammography screening rates using WhatsApp
Time frame: Five months
Comparison of mammography screening rates using an online radiology booking platform, a message with a radiology practice number, to a standard message, all delivered by WhatsApp.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Feb 2025.
- Individual participant dataSharing planned: Yes. Anonymized data will be shared with Wits collaborators
Related trials for Breast Cancer Female
Not yet recruiting
Decision Support for Chemoprevention
Breast Cancer
Active, not recruitingPhase 2
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Risk Reduction, Breast Cancer
Active, not recruitingObservational study
Diet, Hepcidin, and Chemotherapy RDI
Breast Cancer Female, Ovarian Cancer
RecruitingPhase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Ovarian Neoplasms, Breast Neoplasms
Recruiting
Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy
Microbiome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Adele Walker principal investigator
Discovery
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Standard message, Radiology booking site link. and Radiology practice telephone numbers in people with Breast Cancer Female, run by Wits Health Consortium (Pty) Ltd at 1 site in South Africa.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Comparison of mammography screening rates using WhatsApp (time frame: Five months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2025.